Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Dec;38(3):811–816. doi: 10.1128/iai.38.3.811-816.1982

In vitro effect of hydrocortisone on the attachment and ingestion phases of immunoglobulin G- and complement component 3b-mediated phagocytosis by human neutrophils.

J Forslid, J Hed
PMCID: PMC347820  PMID: 6295946

Abstract

The fluorescence quenching method (FQ method) was used to investigate the effect of hydrocortisone on the attachment and ingestion phases of immunoglobulin G (IgG)- and complement component 3b (C3b)-mediated phagocytosis by human neutrophils (PMNs). The results were compared with metabolic activity (O2- release) of the phagocytes. When the PMNs were treated with 5 X 10(-5) M hydrocortisone or more, both IgG-mediated and C3b-mediated interactions decreased. The number of intracellular particles decreased as the total number of PMN-associated particles decreased, indicating an effect mainly on particle attachment. This was substantiated by the fact that pretreatment of the PMN with cytochalasin B resulted in a hydrocortisone dose-related decrease of interacting particles. The FQ method made it possible to quantify the stimulus-phagocyte interaction in relation to the metabolic response. Superoxide anion release decreased at the highest concentration of hydrocortisone used (5 X 10(-3) M), which merely reflected the decreased number of interacting particles. No reduction in metabolic activation was obtained when the superoxide anion release was correlated with the number of interacting yeast-IgG particles. The results indicate that hydrocortisone primarily affects the binding capacity of Fc and C3b receptors, resulting in decreased metabolic activation. The effector functions, e.g., ingestion and metabolic activation, were not affected by hydrocortisone in this study.

Full text

PDF
811

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON F., Jr, ADCOCK M. H. FAILURE OF PRETREATMENT WITH GLUCOCORTICOIDS TO MODIFY THE PHAGOCYTIC AND BACTERICIDAL CAPACITY OF HUMAN LEUKOCYTES FOR ENCAPSULATED TYPE I PNEUMOCOCCUS. J Bacteriol. 1965 May;89:1256–1261. doi: 10.1128/jb.89.5.1256-1261.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atkinson J. P., Schreiber A. D., Frank M. M. Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes. J Clin Invest. 1973 Jun;52(6):1509–1517. doi: 10.1172/JCI107325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boxer L. A., Richardson S. B., Baehner R. L. Effects of surface-active agents on neutrophil receptors. Infect Immun. 1978 Jul;21(1):28–33. doi: 10.1128/iai.21.1.28-33.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  5. Chretien J. H., Garagusi V. F. Corticosteroid effect on phagocytosis and NBT reduction by human polymorphonuclear neutrophils. J Reticuloendothel Soc. 1972 Apr;11(4):358–367. [PubMed] [Google Scholar]
  6. Cooper M. R., DeChatelet L. R., McCall C. E. The in vitro effect of steroids on polymorphonuclear leukocyte metabolism. Proc Soc Exp Biol Med. 1972 Dec;141(3):986–990. doi: 10.3181/00379727-141-36916. [DOI] [PubMed] [Google Scholar]
  7. Curnutte J. T., Babior B. M. Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes. J Clin Invest. 1974 Jun;53(6):1662–1672. doi: 10.1172/JCI107717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dale D. C., Fauci A. S., Wolff S. M. Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. N Engl J Med. 1974 Nov 28;291(22):1154–1158. doi: 10.1056/NEJM197411282912203. [DOI] [PubMed] [Google Scholar]
  9. Dale D. C., Petersdorf R. G. Corticosteroids and infectious diseases. Med Clin North Am. 1973 Sep;57(5):1277–1287. doi: 10.1016/s0025-7125(16)32228-3. [DOI] [PubMed] [Google Scholar]
  10. Dannenberg A. M., Jr The antinflammatory effects of glucocorticosteroids. A brief review of the literature. Inflammation. 1979 Jul;3(3):329–343. doi: 10.1007/BF00914190. [DOI] [PubMed] [Google Scholar]
  11. Davies P., Fox R. I., Polyzonis M., Allison A. C., Haswell A. D. The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. Lab Invest. 1973 Jan;28(1):16–22. [PubMed] [Google Scholar]
  12. Fauci A. S., Dale D. C., Balow J. E. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976 Mar;84(3):304–315. doi: 10.7326/0003-4819-84-3-304. [DOI] [PubMed] [Google Scholar]
  13. Fauci A. S. Immunosuppressive and anti-inflammatory effects of glucocorticoids. Monogr Endocrinol. 1979;12:449–465. doi: 10.1007/978-3-642-81265-1_24. [DOI] [PubMed] [Google Scholar]
  14. Fuenfer M. M., Carr E. A., Jr, Polk H. C., Jr The effect of hydrocortisone on superoxide production by leukocytes. J Surg Res. 1979 Jul;27(1):29–35. doi: 10.1016/0022-4804(79)90106-9. [DOI] [PubMed] [Google Scholar]
  15. GREENDYKE R. M., BRADLEY E. M., SWISHER S. N. STUDIES OF THE EFFECTS OF ADMINISTRATION OF ACTH AND ADRENAL CORTICOSTEROIDS ON ERYTHROPHAGOCYTOSIS. J Clin Invest. 1965 May;44:746–753. doi: 10.1172/JCI105187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Handin R. I., Stossel T. P. Effect of corticosteroid therapy on the phagocytosis of antibody-coated platelets by human leukocytes. Blood. 1978 May;51(5):771–779. [PubMed] [Google Scholar]
  17. Hed J., Stendahl O. Differences in the ingestion mechanisms of IgG and C3b particles in phagocytosis by neutrophils. Immunology. 1982 Apr;45(4):727–736. [PMC free article] [PubMed] [Google Scholar]
  18. Kaplan G. Differences in the mode of phagocytosis with Fc and C3 receptors in macrophages. Scand J Immunol. 1977;6(8):797–807. doi: 10.1111/j.1365-3083.1977.tb02153.x. [DOI] [PubMed] [Google Scholar]
  19. Lehmeyer J. E., Johnston R. B., Jr Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue-bound IgG. Clin Immunol Immunopathol. 1978 Apr;9(4):482–490. doi: 10.1016/0090-1229(78)90144-7. [DOI] [PubMed] [Google Scholar]
  20. Levine P. H., Hardin J. C., Scoon K. L., Krinsky N. I. Effect of corticosteroids on the production of superoxide and hydrogen peroxide and the appearance of chemiluminescence by phagocytosing polymorphonuclear leukocytes. Inflammation. 1981 Mar;5(1):19–27. doi: 10.1007/BF00910776. [DOI] [PubMed] [Google Scholar]
  21. MARGOLIASH E., FROHWIRT N. Spectrum of horse-heart cytochrome c. Biochem J. 1959 Mar;71(3):570–572. doi: 10.1042/bj0710570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MacGregor R. R., Macarak E. J., Kefalides N. A. Comparative adherence of granulocytes to endothelial monolayers and nylon fiber. J Clin Invest. 1978 Mar;61(3):697–702. doi: 10.1172/JCI108981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mantovani B., Rabinovitch M., Nussenzweig V. Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med. 1972 Apr 1;135(4):780–792. doi: 10.1084/jem.135.4.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McMillan R., Longmire R. L., Tavassoli M., Armstrong S., Yelenosky R. In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura. N Engl J Med. 1974 Jan 31;290(5):249–251. doi: 10.1056/NEJM197401312900505. [DOI] [PubMed] [Google Scholar]
  25. Okuda K., Tadokoro I., Noguchi Y. The metabolic and phagocytic activities of leukocytes from patients receiving corticosteroid and radiation therapy, and patients with bacterial infections. Jpn J Microbiol. 1975 Apr;19(2):105–113. doi: 10.1111/j.1348-0421.1975.tb00856.x. [DOI] [PubMed] [Google Scholar]
  26. Persellin R. H., Ku L. C. Effects of steroid hormones on human polymorphonuclear leukocyte lysosomes. J Clin Invest. 1974 Oct;54(4):919–925. doi: 10.1172/JCI107832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rinehart J. J., Balcerzak S. P., Sagone A. L., LoBuglio A. F. Effects of corticosteroids on human monocyte function. J Clin Invest. 1974 Dec;54(6):1337–1343. doi: 10.1172/JCI107880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schreiber A. D., Parsons J., McDermott P., Cooper R. A. Effect of corticosteroids on the human monocyte IgG and complement receptors. J Clin Invest. 1975 Nov;56(5):1189–1197. doi: 10.1172/JCI108196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stendahl O., Tagesson C., Magnusson K. E., Edebo L. Physiochemical consequences of opsonization of Salmonella typhimurium with hyperimmune IgG and complement. Immunology. 1977 Jan;32(1):11–18. [PMC free article] [PubMed] [Google Scholar]
  30. Thompson E. B. Glucocorticoids and lysosomes. Monogr Endocrinol. 1979;12:575–581. doi: 10.1007/978-3-642-81265-1_31. [DOI] [PubMed] [Google Scholar]
  31. Verp M., Karpatkin S. Effect of plasma, steroids, or steroid products on the adhesion of human opsonized thrombocytes to human leukocytes. J Lab Clin Med. 1975 Mar;85(3):478–486. [PubMed] [Google Scholar]
  32. Zigmond S. H., Hirsch J. G. Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis. Exp Cell Res. 1972 Aug;73(2):383–393. doi: 10.1016/0014-4827(72)90062-6. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES